A Retrospective Chart Review of 809 Patients with Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices
Sign Up to like & getrecommendations! Published in 2022 at "Acta Haematologica"
DOI: 10.1159/000526599
Abstract: Introduction: This analysis reports demographic and clinical characteristics of patients with physician-diagnosed essential thrombocythemia (ET) receiving cytoreductive therapy in US community clinical practice. Methods: Patient characteristics, medical history, diagnostic test results, signs/symptoms, treatment patterns, and… read more here.
Keywords: oncology; receiving cytoreductive; cytoreductive therapy; physician diagnosed ... See more keywords
ACE inhibitors and cytoreductive therapy in polycythemia vera.
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood-2016-11-752600
Abstract: To the editor: In a large international cohort of contemporary polycythemia vera (PV) patients[1][1] recruited at diagnosis and treated according to European LeukemiaNet recommendations,[2][2] the postdiagnosis total major thrombosis rate was 2.62% patients per year,… read more here.
Keywords: polycythemia vera; cytoreductive therapy; inhibitors cytoreductive; ace inhibitors ... See more keywords